Exousia Bio (LMMY) Cost of Revenue (2024 - 2025)

Exousia Bio's (LMMY) quarterly Cost of Revenue came in at $1317.0 in Q4 2025, down 81.84% quarter-over-quarter from $7251.0 in Q2 2025.

Exousia Bio (LMMY) Cost of Revenue (2024 - 2025) Analysis & Trends

Exousia Bio has disclosed Cost of Revenue across 2 years of filings, most recently posting $1317.0 for Q4 2025.

Cost of Revenue for Q4 2025 came in at $1317.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was $8568.0 (down 32.36% YoY), and the FY2025 annual result was $7251.0, down 24.99% from the prior year.
Cost of Revenue came in at $1317.0 for Q4 2025 at Exousia Bio, down from $7251.0 in the prior quarter.
In the past five years, Cost of Revenue ranged from a high of $9667.0 in Q2 2024 to a low of $1317.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	51Talk Online Education	7.03 Bn	6.99 Bn	22.18 Mn	20.41 Mn
2	Laureate Education	5.22 Bn	5.06 Bn	-16.39 Mn	289.01 Mn
3	Graham Holdings	5.09 Bn	4.08 Bn	841.00 Mn	394.99 Mn
4	Covista	4.40 Bn	4.40 Bn	276.31 Mn	210.72 Mn
5	Stride	4.17 Bn	3.36 Bn	231.57 Mn	398.31 Mn
6	Grand Canyon Education	3.94 Bn	3.69 Bn	244.77 Mn	63.99 Mn
7	McGraw Hill	2.19 Bn	1.94 Bn	388.89 Mn	74.83 Mn
8	Universal Technical Institute	2.14 Bn	1.97 Bn	103.97 Mn	117.43 Mn
9	Perdoceo Education	2.13 Bn	1.45 Bn	174.68 Mn	47.07 Mn
10	Exousia Bio	-	-	-62,108.00	1,317.00

Download Data